To find the efficacy of Splenic Artery Ligation in Liver Transplantation.

Splenic Artery Ligation in Liver Transplantation – A Randomised Controlled Trial (SALT TRIAL) - SALT

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/11/077009

Enrollment

100

Registered

2024-11-19

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Splenic artery ligation: Patients who fulfill the criteria will undergo a surgical ligation of Splenic artery after randomisation. Control Intervention1: No splenic artery ligation: Pat

Eligibility

Inclusion criteria

Inclusion criteria: -Age more than 18yrs -Patients undergoing Primary LDLT using a right lobe graft.

Exclusion criteria

Exclusion criteria: -DDLT -LDLT with left lobe grafts -LDLT for acute liver failure -Re-transplant -Pediatric Liver Transplantation -Refusal to participate in study

Design outcomes

Primary

Measure	Time frame
Early allograft dysfunctionTimepoint: 10 days	—

Secondary

Measure	Time frame
morbidity post operativeTimepoint: 30 day;bilirubinTimepoint: 14 days;INRTimepoint: 14 days;AscitesTimepoint: 14 days;PlateletsTimepoint: 14 days	—

Countries

India

Contacts

Public ContactPrithiviraj Nabi

Dr.Rela Institute and Medical center

drprithivi.n@gmail.com704917349

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026